UNSPSC 51182069: Testosterone cypionate

This classification denotes a therapeutic testosterone, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M0XW1UBI14. European Medicines Agency schedules Testosterone cipionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04734MIG. Testosterone cypionate generally arises in the molecular formula C27H40O3. The term 'testosterone cypionate' is a U.S. Pharmacopeial Convention designation. Most nations, for tariff and trade purposes, schedule testosterone cypionate under HS 29372900.

As of Q4 2014, TESTOSTERONE CYPIONATE remains US FDA's Preferred Term for this commodity. Testosterone cypionate bears US NLM identifiers UMLS ID C0076181 and NCI Concept Code C1246. SMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4CCCC4)CCC5=CC(=O)CC[C@]35C.

UNSPSC 51182069 Testosterone cypionate is a Commodity code for a controlled pharmaceutical product that state and local governments procure through health departments, correctional facilities, public health clinics, and medical facilities operated by counties and municipalities. The code covers testosterone cypionate, an injectable anabolic steroid used in clinical and correctional settings for hormone replacement therapy, treatment of hypogonadism, and other medically approved uses under licensed practitioner supervision. State and local health agencies and correctional departments manage procurement through established pharmaceutical supply chains, often leveraging standing agreements with wholesale distributors and pharmaceutical vendors subject to DEA controlled-substance reporting and state pharmacy board oversight.

The source provides no recent state or local contract opportunities tagged to this code. Without posted RFP, RFQ, IFB, or ITB activity in the most-recent-opportunities block, procurement patterns, issuing-body concentration, and geographic activity cannot be characterized from current market signals. Procurement of controlled pharmaceuticals at the state and local level typically occurs through routine standing orders and renewal contracts rather than competitive solicitations, which may explain the absence of posted opportunities under this specific Commodity code.